Stay updated on Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial

Sign up to get notified when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T01:04:00.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 appears on the page; no changes to study details, eligibility criteria, or outcome measures are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:16:53.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Banner notice about a lapse in government funding and NIH operating status was added, and the site revision was updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:24:53.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The updates add a glossary toggle and update page metadata, including a new 'Last Update Submitted that Met QC Criteria' field and 'Revision: v3.4.0', while removing the older 'Last Update Submitted that met QC Criteria', the 'No FEAR Act data' label, and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:48:09.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. This appears to be a maintenance update and does not modify study information or essential content.
    Difference
    0.1%
    Check dated 2026-01-14T03:17:45.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new Locations section was added listing study sites across Alabama, California, Florida, Georgia, Michigan, and North Carolina. The previous per-state location headings were removed, and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.7%
    Check dated 2025-12-23T20:56:51.000Z thumbnail image

Stay in the know with updates to Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.